STOCK TITAN
  1. Home
  2. IRRAF

Irras Stock Price, News & Analysis

IRRAF OTC

Company Description

Irras (OTC: IRRAF) is a publicly traded surgical and medical instrument manufacturing company in the Manufacturing sector.

This page provides a comprehensive overview of IRRAF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
794.8M
Shares outstanding

Latest News

View All
—

IRRAS Announces publication of a Case report from Buffalo General Medical Center, highlights clinical superiority of IRRAflow treatment versus traditional drainage

—

IRRAS Announces Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery, to Advance Use of IRRAflow

—

IRRAS to Present at Redeye

conferences
—

IRRAS AB publishes Year End Report for the period January to December 2020

—

Q4 Report 2020 - invitation to conference call and audiocast

conferences earnings
—

IRRAS Announces Release of Clinical Data that Validates Safety and Effectiveness of IRRAflow System in Treating Chronic Subdural Hematomas

clinical trial

Irras has 7 recent news articles. Key topics include conferences, earnings, clinical trial. View all IRRAF news →

SEC Filings

View All

No SEC filings available for IRRAF.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

IRRAF Company Profile & Sector Positioning

Irras (IRRAF) operates in the Surgical and Medical Instrument Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.